Siegfried Aktie 142932682 / CH1429326825
Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Historisch | Analysen |
21.08.2025 06:30:05
|
Siegfried on track to deliver profitable growth
Siegfried AG / Key word(s): Half Year Results Media Release Ad hoc announcement pursuant to Art. 53 Listing Rules In the first half of 2025, Siegfried (SIX: SFZN) successfully executed its strategy and continued to grow profitably. As expected, the seasonality between the half years is stronger in 2025 compared to previous years. Performance was supported by strong demand for development and manufacturing services for both drug substances and drug products across multiple markets. Profitability further increased, despite inflationary pressures in the U.S. and Germany, the final wave of customer de-stocking, and adverse currency developments. Over CHF 35 million of cash was released as a result of ongoing networking capital optimization, despite a significant increase in inventories for ongoing manufacturing that will convert into revenues in the second half of the year. Execution of the EVOLVE+ strategy remains firmly on track, sharpening Siegfried’s focus on Commercial, Development, and Operational excellence, while laying the foundation for future value creation through targeted M&A. Marcel Imwinkelried, Chief Executive Officer: "In the first half of the year, Siegfried delivered according to plan, laying a solid foundation which allows us to confirm our 2025 outlook. This reflects the strength of our diversified customer base and our efficient operations. The execution of our strategy EVOLVE+ is making rapid progress, setting the course to outpace market growth across the key segments we are operating in and further strengthening our position as a leading CDMO in the pharmaceutical industry." Net sales amounted to CHF 619.5 million, an increase of 1.6% in local currencies (-0.1% in Swiss Francs). The Drug Substances cluster contributed CHF 413.8 million, an increase of 2.1% in local currencies (0.6% in CHF), while Drug Products generated CHF 205.8 million in net sales, an increase of 0.7% in local currencies (-1.5% in CHF). Core EBITDA amounted to CHF 133.9 million (prior period: CHF 132.1 million), resulting in an increased Core EBITDA margin of 21.6% (prior period: 21.3%). Core net profit amounted to CHF 65.7 million (prior period: CHF 71.7 million). This decrease is caused by negative exchange rate differences which reflect a point-in-time view. Cash flow from operating activities increased to CHF 149.6 million (prior period: CHF 118.9 million). Strategic expansions focusing on growth opportunities Outlook confirmed Half-Year Results 2025
About Siegfried Siegfried is active in manufacturing pharmaceutical APIs (and their intermediates) as well as drug products (tablets, capsules, sterile vials, ampoules, cartridges and ointments) for the pharmaceutical industry and provides development services. expect more Siegfried AG End of Inside Information |
Language: | English |
Company: | Siegfried AG |
Untere Brühlstrasse 4 | |
4800 Zofingen | |
Switzerland | |
Phone: | +41 62 746 11 11 |
E-mail: | info@siegfried.ch |
Internet: | https://www.siegfried.ch |
ISIN: | CH1429326825 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 2186524 |
End of Announcement | EQS News Service |
|
2186524 21-Aug-2025 CET/CEST
Nachrichten zu Siegfried Holding AG
29.09.25 |
Siegfried-Aktie legt zu: Tochter Dinamiqs startet neue Produktionsanlage in Schlieren (AWP) | |
29.09.25 |
DINAMIQS opens cGMP manufacturing facility for viral vectors (EQS Group) | |
26.09.25 |
Siegfried-Aktie im Plus: VRP Andreas Casutt tritt 2026 zurück - Beat Walti vorgeschlagen (AWP) | |
26.09.25 |
Change in the Chairmanship of the Board of Directors (EQS Group) | |
11.09.25 |
Siegfried successfully places senior bonds of CHF 300 million (EQS Group) | |
21.08.25 |
Siegfried-Aktie unter Druck: Siegfried bleibt trotz geringem Wachstum bei Prognose (AWP) | |
21.08.25 |
Siegfried on track to deliver profitable growth (EQS Group) | |
17.07.25 |
Siegfried-Aktie schwächer: Stühlerücken in der Geschäftsleitung (AWP) |
Analysen zu Siegfried Holding AG
ETFs oder Dividendenaktien – welcher Weg führt langfristig zum Erfolg
In der BX Swiss Bloggerlounge am Börsentag Zürich 2025 diskutieren Helga Bächler von liebefinanzen.ch, Angela Mygind (MissFinance) und Olivia Hähnel (BX Swiss) über zwei Strategien mit dem gleichen Ziel: finanzielle Freiheit. Im Gespräch geht es um die entscheidende Frage: 👉 Ist passives Investieren mit ETFs wirklich der bessere Weg oder lohnt sich aktives Stock-Picking doch mehr?
💬 Themen im Überblick:
💡 Vor- & Nachteile von ETFs und Einzelaktien
💡 Welche Risiken Anlegerinnen und Anleger kennen sollten
💡 Wie Dividenden motivieren können
💡 Tipps für Einsteigerinnen und Einsteiger
💡 Umgang mit Rückschlägen an der Börse
👉🏽 Jetzt auch auf BXplus anmelden und von exklusiven Inhalten rund um Investment & Trading profitieren!
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Berichtssaison nimmt mit US-Banken Fahrt auf: US-Börsen schliessen uneinheitlich -- SMI letztlich im Minus -- DAX endet in der Verlustzone -- Asiens Börsen schliessen schwachAm heimischen Aktienmarkt prägten Verluste den Handel. Am deutschen Aktienmarkt ging es ebenfalls abwärts. Die Wall Street zeigte sich am Dienstag uneinheitlich. Auch an den grössten Börsen in Asien waren rote Vorzeichen zu sehen.